Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Logothetis

Showing results (131-140 of 430) with videos related to

Pageof 43
Sort By:
Cancer|September 15, 1987
Sarcomatoid renal cell carcinoma. A treatable entityA Sella, C J Logothetis, J Y Ro, et al.
Cancer|January 1, 1984
The prognostic significance of endodermal sinus tumor histology among patients treated for stage III nonseminomatous germ cell tumors of the testesC J Logothetis, M L Samuels, A Trindade, et al.
Pediatrics|November 1, 1971
Intelligence and behavioral patterns in patients with Cooley's anemia (homozygous beta-thalassemia); a study based on 138 consecutive casesJ Logothetis, M Haritos-Fatouros, M Constantoulakis, et al.
Urology|February 1, 1991
Association of germ cell tumors and Hodgkin's diseaseF H Dexeus, R Kilbourn, C Chong, et al.
Cancer Treatment Reports|January 1, 1985
Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumorsC J Logothetis, M L Samuels, D E Selig, et al.
Urologic Oncology|January 13, 2011
Paclitaxel in extensively pretreated nonseminomatous germ cell tumorsA Nazario, R J Amato, L Hutchinson, et al.
British Journal of Urology|June 1, 1991
Cisplatin combination chemotherapy for elderly patients with urothelial tumoursA Sella, C J Logothetis, F H Dexeus, et al.
The Journal of Urology|January 1, 1987
Complete responses in metastatic transitional cell carcinoma of the prostate with cisplatin regimensF H Dexeus, C J Logothetis, M L Samuels, et al.
Plos One|August 5, 2009
GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an exampleIvan P Gorlov, Gary E Gallick, Olga Y Gorlova, et al.
Anti-Cancer Drugs|August 21, 2002
Enhanced suppression of prostate tumor growth by combining C-CAM1 gene therapy and angiogenesis inhibitor TNP-470Yeong-Shiau Pu, Kim-Anh Do, Weiping Luo, et al.
Pageof 43

Showing results (131-140 of 430) with videos related to

Sort By:
Pageof 43
Cancer|September 15, 1987
Sarcomatoid renal cell carcinoma. A treatable entityA Sella, C J Logothetis, J Y Ro, et al.
Cancer|January 1, 1984
The prognostic significance of endodermal sinus tumor histology among patients treated for stage III nonseminomatous germ cell tumors of the testesC J Logothetis, M L Samuels, A Trindade, et al.
Pediatrics|November 1, 1971
Intelligence and behavioral patterns in patients with Cooley's anemia (homozygous beta-thalassemia); a study based on 138 consecutive casesJ Logothetis, M Haritos-Fatouros, M Constantoulakis, et al.
Urology|February 1, 1991
Association of germ cell tumors and Hodgkin's diseaseF H Dexeus, R Kilbourn, C Chong, et al.
Cancer Treatment Reports|January 1, 1985
Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumorsC J Logothetis, M L Samuels, D E Selig, et al.
Urologic Oncology|January 13, 2011
Paclitaxel in extensively pretreated nonseminomatous germ cell tumorsA Nazario, R J Amato, L Hutchinson, et al.
British Journal of Urology|June 1, 1991
Cisplatin combination chemotherapy for elderly patients with urothelial tumoursA Sella, C J Logothetis, F H Dexeus, et al.
The Journal of Urology|January 1, 1987
Complete responses in metastatic transitional cell carcinoma of the prostate with cisplatin regimensF H Dexeus, C J Logothetis, M L Samuels, et al.
Plos One|August 5, 2009
GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an exampleIvan P Gorlov, Gary E Gallick, Olga Y Gorlova, et al.
Anti-Cancer Drugs|August 21, 2002
Enhanced suppression of prostate tumor growth by combining C-CAM1 gene therapy and angiogenesis inhibitor TNP-470Yeong-Shiau Pu, Kim-Anh Do, Weiping Luo, et al.
Pageof 43